WM-202

N/A

Report date: 2026/03/19 17:18:08

Base Information

Drug NameWM-202

Drug Alias NameWM202

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD3Melanoma-associated antigen 4 modulators

TargetsT cell surface glycoprotein CD3Melanoma-associated antigen 4

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesChongqing Genrix Biopharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesGenrix (Shanghai) Biopharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A